Attached files
file | filename |
---|---|
EX-10.24 - EX-10.24 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex1024.htm |
EX-32.1 - EX-32.1 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex321.htm |
EX-31.2 - EX-31.2 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex312.htm |
EX-31.1 - EX-31.1 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex311.htm |
EX-10.26 - EX-10.26 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex1026.htm |
EX-10.25 - EX-10.25 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex1025.htm |
EX-10.23 - EX-10.23 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex1023.htm |
EX-4.2 - EX-4.2 - APPLIED GENETIC TECHNOLOGIES CORP | d864197dex42.htm |
10-K - 10-K - APPLIED GENETIC TECHNOLOGIES CORP | d864197d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-198979) pertaining to the Applied Genetic Technologies Corporation 2001 Stock Option Plan, 2011 Stock Incentive Plan, 2013 Equity and Incentive Plan and the 2013 Employee Stock Purchase Plan, |
(2) | Registration Statement (Form S-3 No. 333-225286) of Applied Genetic Technologies Corporation, and |
(3) | Registration Statement (Form S-8 No. 333-233955) pertaining to the Applied Genetic Technologies Corporation 2013 Equity and Incentive Plan; |
of our report dated September 18, 2020, with respect to the financial statements and financial statement schedule of Applied Genetic Technologies Corporation included in this Annual Report (Form 10-K) of Applied Genetic Technologies Corporation for the year ended June 30, 2020.
/s/ Ernst & Young LLP |
Tampa, Florida |
September 18, 2020 |